Cyclooxygenase-2 in Endometriosis.

Area of Science:

• Gynecological pathology
• Molecular biology
• Pharmacology

Background:

• Endometriosis (EMS) is a prevalent gynecological condition affecting women of reproductive age.
• EMS is characterized by chronic pelvic pain, painful intercourse, and infertility.
• Endometriotic lesions exhibit elevated cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) biosynthesis compared to normal endometrium.

Purpose of the Study:

• To review recent basic research on the role of COX-2 in endometriosis.
• To summarize current COX-2-targeted treatments for EMS.

Main Methods:

• Review of current scientific literature on COX-2 and endometriosis.
• Analysis of molecular mechanisms underlying COX-2 regulation and function in EMS.
• Summary of therapeutic strategies targeting COX-2.

Main Results:

• COX-2 expression is upregulated in EMS due to genetic, immune, and environmental factors, involving intracellular signals like MAPKs.
• COX-2 and its product PGE2 are crucial for EMS development, promoting cell proliferation, invasion, angiogenesis, and pain.
• PGE2 exerts its effects by binding to EP2 and EP4 receptors.

Conclusions:

• High COX-2 levels contribute significantly to the pathophysiology of endometriosis, including pain and infertility.
• Targeting COX-2, through inhibitors, hormone therapy, or glycyrrhizin, represents a viable therapeutic approach for EMS.